STACY QUINN: Open Payments
NPI 1427378512 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$936 in 61 payments from 10 companies in 2025. Trend: 2023 $867 · 2024 $1,231 · 2025 $936
Food & beverage: $936
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $306 |
| ABBVIE INC. | 23 | $227 |
| PFIZER INC. | 18 | $159 |
| Exact Sciences Corporation | 5 | $86 |
| Novo Nordisk Inc | 5 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| GENZYME CORPORATION | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
| Tris Pharma Inc | 1 | $15 |
Products named: FARXIGA, VRAYLAR, NURTEC ODT, Cologuard Collection Kit, UBRELVY, Wegovy, BREZTRI, TRINTELLIX.
Industry payments across KY — which companies pay providers there.
